ArticleBritish journal of cancer2015

The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer.

H B Ragnum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.